The Kratom Council

Latest / Regulation

Regulation

North Dakota's House Voted 86-6 To Regulate Kratom. Its Senate Voted 46-1 To Ban It. The Same Day.

An empty legislative chamber seen down the centre aisle, two identical banks of polished wood desks curving away on either side.

On Thursday, the second day of North Dakota's special session, both chambers of the Legislature voted on kratom, and both voted decisively. The House passed House Bill 1628, which would keep natural leaf kratom legal for adults 21 and older under a licensing regime, by 86 to 6. The Senate passed Senate Bill 2408, which would prohibit kratom in every form and attach criminal penalties to possession, by 46 to 1.

Those two bills cannot both become law as written. Today the chambers swap them, under a deadline the Legislature did not choose. The governor's emergency order that pulled kratom off North Dakota shelves ran 30 days from August 5, which means it lapses today. Whatever the Legislature does before it adjourns is what the state's kratom law is on Saturday morning.

What Each Bill Does

House Bill 1628, brought by Rep. Pat Heinert, R-Bismarck, is a regulatory framework rather than a prohibition. Reporting on the bill describes licensing requirements for processors and retailers, mandatory laboratory testing, labeling standards, and enforcement authority vested in the attorney general over licensees. Products could not be candylike in appearance. Labels would have to carry a full ingredient list, health disclaimers and a recommended serving size. Underage possession would be handled roughly the way underage tobacco possession is handled, with low-level penalties scaled to the person's age. The bill also funds a public health campaign at 20,000 dollars. During floor debate members raised the retailer licensing fee, reported at 10,000 dollars, and asked whether cities and counties could still ban kratom locally. The attorney general's office estimated the program would cost the state close to 3.8 million dollars through 2029.

Senate Bill 2408, brought by Sen. Michelle Axtman, R-Bismarck, goes the other way. It would place kratom alkaloids and their synthetic derivatives in the same schedule of controlled substances that holds LSD and heroin. Criminal exposure would attach not only to sale and distribution but to possession and ingestion, escalating with repetition: an infraction carrying a fine of up to 1,000 dollars at the first offense, rising to a class C felony at a third or subsequent possession offense, punishable by up to five years in prison and a 10,000 dollar fine.

The Senate Bill Changed Shape Before It Passed

When this publication reported on these two bills as they headed into the session, Senate Bill 2408 was a synthetic derivatives measure. It targeted 7-hydroxymitragynine and compounds like it, and left the natural leaf to the House bill. That is what the legislative working group had leaned toward in August, and it is what the bill was drafted to do.

It is not what passed. Axtman amended her own bill to reach natural kratom as well, describing the amended version, as reported, as essentially a blanket ban on all kratom and kratom derivatives. She attributed the change to testimony the chamber heard earlier in the week from medical professionals and members of the public from across the state.

That amendment is the most consequential thing that happened this week, and it is easy to miss inside a vote count. The distinction between the leaf and the concentrated compounds derived from it is the organizing principle of nearly every kratom measure in the country. It is the line the federal government drew in August, when the Drug Enforcement Administration scheduled three 7-OH analogs and the Justice Department said publicly that the action was not aimed at traditional botanical kratom. In North Dakota that line held in the working group in August and was gone from the Senate bill by the first week of September.

What The Margins Actually Say

Read separately, 86 to 6 and 46 to 1 each look like consensus. Read together they describe something else. The Legislature is close to unanimous that the status quo is unacceptable and close to evenly divided, by chamber, on what should replace it. Almost nobody in either chamber voted to do nothing.

That is a change from where this Legislature was eighteen months ago. In the 2025 regular session, House Bill 1101 would have added mitragynine to the state's Schedule I. It failed in the House by 15 votes to 77. The same chamber has now voted 86 to 6 for a licensing regime, and votes today on a bill that goes considerably further than the one it rejected in 2025.

What moved in between was not a new statute but executive action. Gov. Kelly Armstrong declared a public health emergency in early August and signed an order that took kratom products off shelves statewide for 30 days beginning August 5, then called the Legislature back to make a decision permanent. That order expires today. This is the state's second special session in a single year, which the Legislature had not done before.

The Governor Asked For A Ban And Warned Against One Consequence Of It

Armstrong used his State of the State address on Wednesday, reported as the second shortest in state history at just under nine minutes, to ask the Legislature to prohibit kratom in all its forms. He also asked members not to use the session for political grandstanding.

In the same address he raised a concern that sits directly against the bill his chamber allies passed 46 to 1 a day later. He said, as reported, that he did not want to turn someone into a felon in September for buying something that was legally available over the counter in July. Senate Bill 2408 does attach criminal liability to possession and ingestion. Its felony tier is not immediate, arriving at a third offense rather than a first, so the two positions are not flatly contradictory. But the bill that passed the Senate is a possession-crime bill, and the governor who asked for the ban named possession-crime exposure as the thing he wanted to avoid. Whether the House reads that as a reason to hesitate is the open question of the session, and it is being answered today.

Armstrong has also said publicly that people were overdosing and dying from a product available on shelves without regulation or age restriction, and that this is why he acted. That is the state's characterization of the problem it is legislating against. This publication reports it as the official position it is and does not adopt it as a finding of its own.

The Border Argument

One argument raised on the House floor is worth isolating, because it applies to every state ban and is rarely stated as plainly. Rep. Eric Murphy, R-Grand Forks, pointed out during debate that roughly 40 percent of North Dakota's population lives within an hour of the Minnesota border. Minnesota permits kratom sales to adults, and raised its purchase age to 21 earlier this year.

A prohibition inside one state's lines does not remove a product from the region. It relocates the transaction and removes the state's ability to impose testing, labeling and age verification on it. That is an argument about enforcement reach rather than about the substance, and it does not resolve on its own which bill is better policy. It does mean the practical difference between the two bills is narrower than the vote counts suggest.

What Happens Today

The Senate takes up House Bill 1628 and the House takes up Senate Bill 2408. Legislators have acknowledged that passing both would leave conflicting provisions in state law and have said they intend to coordinate the two floor votes. Members were reported to be aiming to adjourn today, ahead of the Labor Day weekend. This report was written on Friday morning, before those votes.

Three outcomes are available. The House passes the ban and North Dakota prohibits kratom in all forms with criminal penalties reaching possession. The House declines and the Senate takes up the regulatory bill instead, leaving the state with a licensing regime and an age limit. Or the chambers fail to reconcile and the session ends with nothing, in which case the emergency order lapses today and kratom returns to North Dakota shelves under no state framework at all. That last outcome is the one nobody in Bismarck has argued for, and it is the reason the clock matters more than the margins.

For the rest of the industry, the North Dakota result matters beyond North Dakota for one reason. Every other jurisdiction now writing kratom rules, including the federal government, has organized its approach around a distinction between the leaf and the concentrated or synthesized compounds derived from it. North Dakota's Senate abandoned that distinction in a single amendment, three weeks after its own working group endorsed it, and lost one vote doing so. Whether that survives the House today is the first real test of whether the leaf-versus-synthetic line is a durable regulatory principle or a temporary convenience.

Sources

← Back to all coverage

Get new reporting by email